As of 2025-12-22, the Fair Value of Harpoon Therapeutics Inc (HARP) is -7.13 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 23.01 USD, the upside of Harpoon Therapeutics Inc is -130.97%.
With the market price of 23.01 USD and our fair value calculation, Harpoon Therapeutics Inc (HARP) is not a good investment. Investing in HARP stocks now will result in a potential loss of 130.97%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -27.37 | -55.57 | -49.91 | -116.72 | -67.73 | -63.46 |
| YoY growth | -62.63% | -103.03% | 10.19% | -133.86% | 41.97% | -49.47% |
| Market Cap (mil) | 492.41 |
| P/E | |
| Forward P/E | -16.10x |
| EPS | -1.43 |
| Avg earnings growth rate | -49.47% |
| TTM earnings | -30.50 |